Wound Debridement Devices Segment to Account for Largest Market Share During 2021-2028

According to our latest research study on "Skin Grafting System Market Forecast to 2028 - COVID-19 Impact and Analysis - by Product Type, Type, Wound Type, and End User," the market is expected to reach US$ 1,348.21 million by 2028 from US$ 832.44 million in 2021; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The report highlights the trends prevailing in the skin grafting system market and the factors governing its growth. The increasing cases of burn injuries, rising prevalence of skin cancer and diabetes, and the growing variety of skin graft sources for the grafting system contribute to the market growth. However, the cost of skin grafting procedures hinders the growth of the skin grafting system market. The report highlights the key factors driving the market and prominent players with their developments in the market.

The COVID-19 pandemic created a public health and economic crisis in many countries across the world. The pandemic adversely affected a large percentage of the population in the first half of 2020. Many regions saw a steep decline in healthcare services, as several elective medical procedures were postponed or canceled, which led to a reduction in footfall at hospitals, clinics, and similar healthcare facilities. A significant percentage of the skin grafting procedures were a part of these elective medical procedures, which were postponed or canceled. Apart from burns, chronic wounds, and a few other wounds, skin grafting is not essential. Therefore, the demand for skin grafting in hospitals and other healthcare facilities fell significantly, which declined the need for consumables and instruments, as well as newer devices and systems. The product development and innovation among market players were also delayed with most medical device companies concentrating on the development of products related to combating the pandemic and other essential medical solutions. Also, global disruption of the supply chains led to an incomplete meeting of demands in various regions, with the supply being affected by delayed production processes, raw material shortage, and affected distribution channels. As the pandemic moved on, the rollout of vaccinations and various social measures to prevent the spread eased the regulations around elective surgeries, leading to a growth in the skin grafting systems market.

Based on product type, the skin grafting system market is segmented into dermatomes, wound debridement devices, skin graft mesher equipment and accessories, and others. The wound debridement devices segment held the largest share of the market in 2021 and is expected to hold the largest share during the forecast period. However, the dermatomes segment is projected to register the highest CAGR during the forecast period. Wound debridement is an essential process prior to the skin grafting process. The process removes any dead tissues or eschar that can contaminate the wound region and lead to sepsis and eventual rejection of the skin graft. Wound debridement devices include water jets and guns along with various consumables, which are essential for disinfection of the wound. Many wound debridement devices and equipment are generally single use, which leads to high demand for the same, thereby increasing the segment size and share.

Zimmer Biomet; B. Braun Medical; Exsurco Medical, Inc.; Aygun Surgical Instruments Co., Inc.; De Soutter Medical; Lutz GmbH & Co. KG; Smith & Nephew; Stryker Corp.; Integra Lifesciences Holdings Corp.; and Humeca BV are among the leading companies operating in the skin grafting system market. These companies have taken various steps and driven innovations, leading to market growth.

The report segments the skin grafting system market as follows:

Based on product type, the skin grafting system market is segmented into dermatomes, wound debridement devices, skin graft mesher equipment and accessories, and others. The market for the dermatomes segment is further segmented into electric dermatomes, drum dermatomes, and others. Similarly, the market for the skin graft mesher equipment and accessories segment is further segmented into mesher cutters, mesher carriers, and other companion products. In terms of type, the skin grafting system market is bifurcated into autograft and allograft. By wound type, the market is segmented into burns, chronic wounds, traumatic wounds, surgical wounds, and others. The market for the chronic wounds segment is subsegmented into diabetic foot ulcers, pressure ulcers, and venous foot ulcers. Based on end user, the skin grafting system market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. The market in North America is further segmented into the US, Canada, and Mexico. The European skin grafting system market is subsegmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. The market in Asia Pacific is subsegmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The skin grafting system market in the Middle East & Africa is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The market in South and Central America is subsegmented into Brazil, Argentina, and the Rest of South and Central America.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com